InvestorsHub Logo

cptjsd

10/30/14 8:32 PM

#15437 RE: Longmoney #15436

I recently traded in most of my stocks for warrants. I am planning 1/4th of the warrants at 6 and 1/2 of them at 10. The other quarter I will let ride with the rest of my stock. I have put a lot of thought into it and it's clearly speculation and wishful thinking on my part.

BelizeMe

10/30/14 9:42 PM

#15438 RE: Longmoney #15436

LongMoney,

I respect your comments but it does not seem like you have intimate knowledge and experience in med-device start ups. That's okay, I am not an expert in some of the things people on this board do for a living.
Let me try and dispel some of the well intentioned but i believe from 25 yrs. experience in med-devices (10 solely in three start-ups) misinformed opinions that say Titan could not effectively bring Sport to market. Certainly, anyone is welcome to their opinion but it needs to be based on facts.
This device will need a specialized sales force. Even if a Stryker or Olympus type acquired SPORT it would require a completely new sales force be put together so why would it make a difference if Titan was putting that together versus another organization? Believe me, bringing in quality management and the first reps can be done very quickly.

I believe some feel that they need to hire 50 capital reps and 50 clinical specialists day one. This is not true and even a larger company would not start this way. You need to start with 10 to 15 reps in strategic areas and grow incrementally from there. It is not just the cost of the sales force you need to consider but the cost of the capital and disposable inventory. They can grow pretty quickly, add and train reps and support personnel each quarter as sales and revenue grows and they get a handle on inventory needs. You must be careful at this point to avoid backorders and give your manufacturing partners time to build adequate inventories. The capital reps can cover large regions at first and respond to what I believe will be a large amount of qualified leads. The market wants a company to grow smartly. Some hospitals may need to wait several months for a unit. That is okay.... In the beginning.
The key is to have well-trained teams supporting the product in the field and growing the all-important razor blade side of the business and having good results.

As far as when I would sell any of my 172,000 shares I am in it for the long haul but will probably sell some increments sometime after FDA clearance to celebrate, some after several quarters of sales, and some after the company reaches profitability. I will probably ride 30-40% of them long-term as I have half of my shares in IRA accounts so I don't have to pay taxes on them in the short-term.

Good luck.

BelizeMe